Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasis
Abstract Background The use of biologic agents has significantly improved the quality of life for patients with chronic skin diseases, and many other autoinflammatory diseases, over the past two decades. Due to the immunosuppressive nature of biologic agents, patients on these treatments are at incr...
Үндсэн зохиолчид: | Corey Stone, Tabrez Sheriff, Yicong Liang, Dédée F. Murrell |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Wiley
2023-09-01
|
Цуврал: | JEADV Clinical Practice |
Нөхцлүүд: | |
Онлайн хандалт: | https://doi.org/10.1002/jvc2.182 |
Ижил төстэй зүйлс
-
Hidradenitis suppurativa and psoriasis coexistence in patients with Down syndrome: A case series
-н: Neslihan Demirel Öğüt, зэрэг
Хэвлэсэн: (2022-09-01) -
Hidradenitis suppurativa and psoriasis: the odd couple
-н: Laura Macca, зэрэг
Хэвлэсэн: (2023-07-01) -
A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with Tildrakizumab
-н: Thomas Damsin
Хэвлэсэн: (2023-06-01) -
Multimodal management of hidradenitis suppurativa
-н: Gregor B.E. Jemec, MD, DMSc
Хэвлэсэн: (2020-06-01) -
Work Impairment in Hidradenitis Suppurativa Compared to Psoriasis: A Cross-Sectional Study
-н: Aikaterini Tsentemeidou, зэрэг
Хэвлэсэн: (2024-10-01)